Crossref
What are the benefits and harms of cladribine for adults with multiple sclerosis (MS)?
Cochrane Clinical Answers · 27.04.2026
DOI: 10.1002/cca.4775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cochrane Clinical Answers, online erschienen am 27.04.2026. Verfasst von Amin Sharifan. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sharifan, A. (2026). What are the benefits and harms of cladribine for adults with multiple sclerosis (MS)?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.4775
Vancouver
Sharifan A. What are the benefits and harms of cladribine for adults with multiple sclerosis (MS)?. Cochrane Clinical Answers. 2026. doi:10.1002/cca.4775
BibTeX
@article{Sharifan2026,
author = {Sharifan, Amin},
title = {What are the benefits and harms of cladribine for adults with multiple sclerosis (MS)?},
journal = {Cochrane Clinical Answers},
year = {2026},
doi = {10.1002/cca.4775}
}
EUVIMED